Patient Safety and Product Quality
Patient Safety & Product Quality
Patient safety and product quality are embedded in the Group’s culture and patient-focused business model, and are fundamental to the integrity of our global brands and businesses.
Through a robust pharmacovigilance process, we monitor the safety of the Group’s marketed and investigational products in a comprehensive and thorough manner. This includes a Risk Evaluation and Mitigation Strategies (REMS) program to mitigate the risks of accidental overdose, misuse and abuse for SUBOXONE® Film and to mitigate the risk of serious harm or death that could result from intravenous self-administration for SUBLOCADE™ in the US. Globally, Risk Management Plans (RMPs) are being put in place to minimize risks outside the US.
The Group is committed to a culture of innovation and quality defined as maintaining patient trust, empowering our workforce and partnering with regulators to drive excellence.
Patient Help Foundation
In 2018, the Indivior Patient Help Foundation provided SUBOXONE® Film product valued at $16.7m through its patient assistance program in the US. Since 2010, the Foundation has provided medication access to an average of 5,000 qualified patients per year.